Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

References

• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet20123791341135122314182
   PubMed Web of Science ®Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest2000117398S401S10843984
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
   PubMed Web of Science ®Google Scholar
• OstergaardCBenfieldTLundgrenJDEugen-OlsenJSoluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcomeScand J Infect Dis200436141915000553
   PubMed Web of Science ®Google Scholar
• MadsenCDSideniusNThe interaction between urokinase receptor and vitronectin in cell adhesion and signallingEur J Cell Biol20088761762918353489
   PubMed Web of Science ®Google Scholar
• PortelliMASiedlinskiMStewartCEGenome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levelsFASEB J20142892393424249636
   PubMed Web of Science ®Google Scholar
• ThunøMMachoBEugen-OlsenJsuPAR: the molecular crystal ballDis Markers20092715717219893210
   PubMed Web of Science ®Google Scholar
• LawnSDMyerLBanganiNVogtMWoodRPlasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South AfricaBMC Infect Dis200774117509133
   PubMed Web of Science ®Google Scholar
• Eugen-OlsenJGustafsonPSideniusNThe serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-BissauInt J Tuberc Lung Dis2002668669212150480
   PubMed Web of Science ®Google Scholar
• WittenhagenPKronborgGWeisNThe plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortalityClin Microbiol Infect20041040941515113317
   PubMed Web of Science ®Google Scholar
• Eugen-OlsenJAndersenOLinnebergACirculating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJ Intern Med201026829630820561148
   PubMed Web of Science ®Google Scholar
• BozinovskiSHutchinsonAThompsonMSerum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817726927818006888
   PubMed Web of Science ®Google Scholar
• SmithDJYerkovichSTTowersMACarrollMLThomasRUphamJWReduced soluble receptor for advanced glycation end-products in COPDEur Respir J20113751652220595148
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: Updated 2014Global Initiative for Chronic Obstructive Lung Disease2014 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdfAccessed July 30, 2014
   Google Scholar
• HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
   PubMed Web of Science ®Google Scholar
• TufvessonEEkbergMBjermerLInflammatory biomarkers in sputum predict COPD exacerbationsLung201319141341623689877
   PubMed Web of Science ®Google Scholar
• MiniatiMMontiSBottaiMCocciFFornaiELubranoVPrognostic value of C-reactive protein in chronic obstructive pulmonary diseaseIntern Emerg Med2011642343021249472
   PubMed Web of Science ®Google Scholar
• ThomsenMDahlMLangePVestboJNordestgaardBGInflammatory biomarkers and comorbidities in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201218698298822983959
   PubMed Web of Science ®Google Scholar
• MobergMVestboJMartinezGLangePRingbaekTPrognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary diseaseScientific World Journal2014201414073624587707
   PubMed Web of Science ®Google Scholar
• KofoedKSchneiderUVScheelTAndersenOEugen-OlsenJDevelopment and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technologyClin Chem2006521284129316690735
   PubMed Web of Science ®Google Scholar
• OstrowskiSRUllumHGokaBQPlasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcomeJ Infect Dis20051911331134115776381
   PubMed Web of Science ®Google Scholar
• DahlMTybjaerg-HansenAVestboJLangePNordestgaardBGElevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011641008101111587987
   PubMed Web of Science ®Google Scholar
• ThorleifssonSJMargretardottirOBGudmundssonGChronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in IcelandRespir Med20091031548155319427181
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMüllerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax200661232816143583
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTAMacCallumPKAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost20008421021510959691
   PubMed Web of Science ®Google Scholar
• Garcia-RioFMiravitllesMSorianoJBEPI-SCAN Steering CommitteeSystemic inflammation in chronic obstructive pulmonary disease: a population-based studyRespir Res2010116320500811
   PubMed Web of Science ®Google Scholar
• DahlMVestboJLangePBojesenSETybjaerg-HansenANordestgaardBGC-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717525025517053205
   PubMed Web of Science ®Google Scholar
• EngströmGSegelstormNEkberg-AronssonMNilssonPMLindgärdeFLöfdahlCGPlasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort studyThorax20096421121518988660
   PubMed Web of Science ®Google Scholar
• DonadelloKScollettaSTacconeFSSoluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patientsJ Crit Care20142914414924120089
   PubMed Web of Science ®Google Scholar